Yoshihiro Konno
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yoshihiro Konno has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Masafumi Kanoto
Department of Diagnostic Radiology, Faculty of Medicine, Yamagata University, Yamagata, Japan
4 shared publicationsToshitada Hiraka
Department of Diagnostic Radiology, Faculty of Medicine, Yamagata University, Yamagata, Japan
3 shared publicationsAkiko Matsuda
Department of Gastroenterology, Faculty of Medicine, Yamagata University, Japan
2 shared publications- Tetsuya Ishizawa
Department of Gastroenterology, Faculty of Medicine, Yamagata University, Japan
2 shared publications Yuki Toyoguchi
Department of Diagnostic Radiology, Faculty of Medicine, Yamagata University, Yamagata, Japan
2 shared publicationsFumika Watarai
Department of Diagnostic Radiology, Yamagata University Faculty of Medicine, Yamagata, Japan
1 shared publication
Latest Publications
- Open Access
- 12 November 2024
- Published by Elsevier in Pancreatology
- Vol. 24 (8) , 1314-1321
Utilization of relative evaluation of pancreatic perfusion CT parameters to support appropriate pancreatic adenocarcinoma diagnosis
- 12 November 2024
- Published by Elsevier in Pancreatology
- Vol. 24 (8) , 1314-1321
Open AccessUtilization of relative evaluation of pancreatic perfusion CT parameters to support appropriate pancreatic adenocarcinoma diagnosis
- 17 January 2023
- Published by Springer Nature in European Radiology
- Vol. 33 (7) , 5131-5141
A retrospective preliminary study of intrapancreatic late enhancement as a noteworthy imaging finding in the early stages of pancreatic adenocarcinoma
Objective To characterize intrapancreatic late enhancement (ILE) observed in the early stages of pancreatic adenocarcinoma (PAC). Methods Among 203 patients pathologically diagnosed with PAC between October 2011 and February 2021, 32 patients with pre-diagnostic abdominal contrast-enhanced CT performed from 6 months to 5 years before the diagnosis were enrolled in this study. Indirect findings (IFs) on pre-diagnostic CT, including ILE, were evaluated and examined for various clinical data and time intervals to diagnosis (TIDs). The detected ILE was quantitatively evaluated, and the effect of ILE awareness on lesion detection by two radiologists and their interobserver agreement were assessed. Results Among the 32 patients, 23 showed IFs. ILE was observed in 14 patients (63%), with a median TID of 17 months (interquartile ratio [IQR]: 9.3–42.3). ILE alone was observed in eight patients (35%), ILE with focal pancreatic parenchymal atrophy (FPPA) was observed in five patients (22%), and ILE with main pancreatic duct abnormalities (MPDA) was observed in one patient (4%). Pancreatic head lesions were significantly more frequent in patients with ILE alone than in patients with FPPA or MPDA (p = 0.026). The median long-axis diameters of the region with ILE and ILE-to-pancreas contrast were 10 (IQR: 5–11) mm and 24 (IQR: 17–33) HU, respectively. Awareness of ILE led observers to detect two or three more pancreatic head lesions, and interobserver agreement increased from poor agreement (k = 0.17) to moderate agreement (k = 0.55). Conclusion ILE is a significant IF for early PAC detection. Key Points • Intrapancreatic late enhancement (ILE) is a significant indirect finding in the early detection of pancreatic adenocarcinoma. • ILE without other indirect findings is expected to help detect pancreatic head lesions. • Image evaluation focusing on ILE can increase lesion detection and improve the interobserver agreement.
- 17 January 2023
- Published by Springer Nature in European Radiology
- Vol. 33 (7) , 5131-5141
A retrospective preliminary study of intrapancreatic late enhancement as a noteworthy imaging finding in the early stages of pancreatic adenocarcinoma
Objective To characterize intrapancreatic late enhancement (ILE) observed in the early stages of pancreatic adenocarcinoma (PAC). Methods Among 203 patients pathologically diagnosed with PAC between October 2011 and February 2021, 32 patients with pre-diagnostic abdominal contrast-enhanced CT performed from 6 months to 5 years before the diagnosis were enrolled in this study. Indirect findings (IFs) on pre-diagnostic CT, including ILE, were evaluated and examined for various clinical data and time intervals to diagnosis (TIDs). The detected ILE was quantitatively evaluated, and the effect of ILE awareness on lesion detection by two radiologists and their interobserver agreement were assessed. Results Among the 32 patients, 23 showed IFs. ILE was observed in 14 patients (63%), with a median TID of 17 months (interquartile ratio [IQR]: 9.3–42.3). ILE alone was observed in eight patients (35%), ILE with focal pancreatic parenchymal atrophy (FPPA) was observed in five patients (22%), and ILE with main pancreatic duct abnormalities (MPDA) was observed in one patient (4%). Pancreatic head lesions were significantly more frequent in patients with ILE alone than in patients with FPPA or MPDA (p = 0.026). The median long-axis diameters of the region with ILE and ILE-to-pancreas contrast were 10 (IQR: 5–11) mm and 24 (IQR: 17–33) HU, respectively. Awareness of ILE led observers to detect two or three more pancreatic head lesions, and interobserver agreement increased from poor agreement (k = 0.17) to moderate agreement (k = 0.55). Conclusion ILE is a significant IF for early PAC detection. Key Points • Intrapancreatic late enhancement (ILE) is a significant indirect finding in the early detection of pancreatic adenocarcinoma. • ILE without other indirect findings is expected to help detect pancreatic head lesions. • Image evaluation focusing on ILE can increase lesion detection and improve the interobserver agreement.
- 1 October 2020
- Published by Elsevier in Pancreatology
- Vol. 20 (7) , 1406-1412
Pancreatic perfusion imaging method that reduces radiation dose and maintains image quality by combining volumetric perfusion CT with multiphasic contrast enhanced-CT
- 1 October 2020
- Published by Elsevier in Pancreatology
- Vol. 20 (7) , 1406-1412
Pancreatic perfusion imaging method that reduces radiation dose and maintains image quality by combining volumetric perfusion CT with multiphasic contrast enhanced-CT
- 14 June 2020
- Published by SAGE Publications in Acta Radiologica
- Vol. 65 (4) , 383-391
Clinical and image features: large-vessel vasculitis after granulocyte colony stimulating factor administration
Background: Granulocyte colony stimulating factor (G-CSF) is known to cause vasculitis, mainly in the small vessels. Several cases of large-vessel vasculitis (LVV) caused by G-CSF have recently been reported in the literature; we retrospectively suspect that some cases of LVV in our institution were associated with administration of G-CSF. Purpose: To evaluate the clinical and radiological findings in our cases and to compare them with those in previous reports. Material and Methods: We retrospectively evaluated clinical and radiological findings in four cases of LVV that occurred after administration of G-CSF in our institution. We also reviewed papers on G-CSF-related LVV and compared their findings to ours. Results: G-CSF-related LVV occurred in patients aged > 50 years and more frequently in women. Most patients developed vasculitis within 15 days after the last administration. While 14/16 patients were symptomatic, the remaining two patients were asymptomatic and diagnosed incidentally. In all cases, laboratory inflammatory markers increased, but there were no autoantibodies that clearly indicated other autoimmune vasculitis. Computed tomography revealed elevated soft tissue density around the affected vessels. Conclusion: LVV is among the potential adverse events of G-CSF administration. We should keep this outcome in mind when we interpret medical images of patients with previous G-CSF treatment history even if they are asymptomatic.
- 14 June 2020
- Published by SAGE Publications in Acta Radiologica
- Vol. 65 (4) , 383-391
Clinical and image features: large-vessel vasculitis after granulocyte colony stimulating factor administration
Background: Granulocyte colony stimulating factor (G-CSF) is known to cause vasculitis, mainly in the small vessels. Several cases of large-vessel vasculitis (LVV) caused by G-CSF have recently been reported in the literature; we retrospectively suspect that some cases of LVV in our institution were associated with administration of G-CSF. Purpose: To evaluate the clinical and radiological findings in our cases and to compare them with those in previous reports. Material and Methods: We retrospectively evaluated clinical and radiological findings in four cases of LVV that occurred after administration of G-CSF in our institution. We also reviewed papers on G-CSF-related LVV and compared their findings to ours. Results: G-CSF-related LVV occurred in patients aged > 50 years and more frequently in women. Most patients developed vasculitis within 15 days after the last administration. While 14/16 patients were symptomatic, the remaining two patients were asymptomatic and diagnosed incidentally. In all cases, laboratory inflammatory markers increased, but there were no autoantibodies that clearly indicated other autoimmune vasculitis. Computed tomography revealed elevated soft tissue density around the affected vessels. Conclusion: LVV is among the potential adverse events of G-CSF administration. We should keep this outcome in mind when we interpret medical images of patients with previous G-CSF treatment history even if they are asymptomatic.
- 1 December 2015
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 33 (10) , 1253-1257
Detectability and anatomical correlation of middle ear cholesteatoma using fused thin slice non-echo planar imaging diffusion-weighted image and magnetic resonance cisternography (FTS-nEPID)
- 1 December 2015
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 33 (10) , 1253-1257
Detectability and anatomical correlation of middle ear cholesteatoma using fused thin slice non-echo planar imaging diffusion-weighted image and magnetic resonance cisternography (FTS-nEPID)
- Open Access
- 1 January 2014
- Published by Japanese Society for Magnetic Resonance in Medicine in Magnetic Resonance in Medical Sciences
- Vol. 13 (2) , 123-126
Clinical Significance of Mammillary Body Enhancement in Wernicke Encephalopathy: Report of 2 Cases and Review of the Literature
In 2 cases of Wernicke encephalopathy in which the initial symptom was double vision, the only abnormal finding on magnetic resonance (MR) imaging was abnormal enhancement of the mammillary bodies. The mammillary bodies are the region most vulnerable to abnormal enhancement. Because MR imaging with contrast enhancement can detect such abnormal enhancement at an early stage, it should be performed more often in patients with oculomotor disorders to avoid underdiagnosis of Wernicke encephalopathy.
- 1 January 2014
- Published by Japanese Society for Magnetic Resonance in Medicine in Magnetic Resonance in Medical Sciences
- Vol. 13 (2) , 123-126
Open AccessClinical Significance of Mammillary Body Enhancement in Wernicke Encephalopathy: Report of 2 Cases and Review of the Literature
In 2 cases of Wernicke encephalopathy in which the initial symptom was double vision, the only abnormal finding on magnetic resonance (MR) imaging was abnormal enhancement of the mammillary bodies. The mammillary bodies are the region most vulnerable to abnormal enhancement. Because MR imaging with contrast enhancement can detect such abnormal enhancement at an early stage, it should be performed more often in patients with oculomotor disorders to avoid underdiagnosis of Wernicke encephalopathy.